Compounding Chemotherapy Companies

Latest Compounding Chemotherapy Companies Update

• 
  Nov 2023: Siemens Healthineers, a well-known medical technology manufacturer, has chosen Baxter Planning as its long-term maintenance supply chain partner. Baxter Planning is the industry leader in providing technology for service parts management. Baxter Planning's end-to-end predictive technology, BaxterPredict, will be utilized by Siemens Healthineers to support the worldwide Service Supply Chain at Siemens Healthineers Customer Services. Siemens Healthineers chose Baxter Planning following a thorough examination because of their industry-leading Service Parts Management solutions and domain knowledge. With the slogan "Your Partners in Planning" and numerous industry honors, Baxter Planning has earned the distinction of providing its clients with expert advice from the most competent professionals in the field thanks to its sophisticated support system and Center of Excellence (CoE).

• 
  Jul 2023: Grifols has finished enrolling patients in its Phase III PRECIOSA clinical trial, which aims to extend the survival duration of patients with decompensated cirrhosis by administering long-term albutein (albumin-human injectable) therapy. The purpose of the multi-center, open-label, regulated, randomized, parallel-group trial is to evaluate the safety and effectiveness of Grifols Albutein in combination with conventional medical care for patients with decompensated cirrhosis who are in the waiting period for a transplant. Over 400 patients have been enrolled in 69 North American and European locations. For a maximum of 12 months, they will be arbitrarily assigned in a 1:1 ratio to get albutein or routine care every eight to twelve days.

• Braun Melsungen AG

• Pfizer Inc.

• Baxter

• Grifols SA

• The Metrix Company

• Added Pharma

• Equashield

• Millers Pharmacy